Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) On October 28, 2009, Margaret G. McGlynn, R.Ph. was elected to the Board of
Directors of Amicus Therapeutics, Inc. (the "Company"). Ms. McGlynn will join
the Board of Directors as an independent director. Ms. McGlynn has not yet been
appointed to any Board committees.
There is no arrangement or understanding between Ms. McGlynn and any other
person pursuant to which Ms. McGlynn was elected as director of the Company.
There are no relationships or transactions in which Ms. McGlynn has or will have
an interest, or was or is a party, requiring disclosure under Item 404(a) of
Regulation S-K.
A copy of the press release announcing Ms. McGlynn's election is furnished as
Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits .
99.1 Press Release, dated November 3, 2009
